SCHEMBL29324427

SCHEMBL29324427

O=CNCCn1cc(C(=O)O)c(=O)c2cc3c(cc21)OC(F)(F)O3

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
HPGD P15428 5/20 0.47
KDM4E B2RXH2 5/20 0.47
HSD17B10 Q99714 4/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
APEX1 P27695 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
DRD3 P35462 1/20 0.37
LMNA P02545 3/20 0.37
TSHR P16473 2/20 0.37
POLB P06746 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
RAB9A P51151 1/20 0.37
TOP1 P11387 3/20 0.36
RXFP1 Q9HBX9 2/20 0.35
HTT P42858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29324423 0.74 KMT2A (0.48) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL11669157 0.70 ALDH1A1 (0.75) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL29324407 0.68 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL29324454 0.68 KMT2A (0.41) ALDH1A1HPGDKDM4EHSD17B10MEN1
SCHEMBL30185626 0.67 ALDH1A1 (0.81) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL29324351 0.65 ALDH1A1 (0.62) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL499644 0.65 ALDH1A1 (0.68) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL27794869 0.65 ALDH1A1 (0.72) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
SCHEMBL7252159 0.64 KDM4E (0.77) ALDH1A1HPGDKDM4EHSD17B10CYP1A2
Oxolinic Acid SCHEMBL637058 0.64 KDM4E (1.00) ALDH1A1HPGDKDM4EHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151425-A1 COMPOUNDS AND METHOD FOR TREATING HIV INFECTION THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2024-07-18 WO disclosed